These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1911617)

  • 21. Two additional examples of non-transfusion-stimulated anti-Kell.
    Clark A; Monaghan WP; Martin CA
    Am J Med Technol; 1981 Dec; 47(12):983-4. PubMed ID: 7332023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell antigens. The fetus as a patient.
    Huntley B
    Lancet; 2001 Dec; 358 Suppl():S58. PubMed ID: 11784607
    [No Abstract]   [Full Text] [Related]  

  • 23. Prenatal diagnosis of anoxic cerebral lesions caused by profound fetal anemia secondary to maternal red blood cell alloimmunization.
    Carbonne B; Nguyen A; Cynober E; Castaigne V; Cortey A; Brossard Y
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):442-4. PubMed ID: 18669757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Febrile Neutropenia following Parvovirus B19 Infection and Cross Anti-Kell Reaction to E. Coli in Pregnancy.
    Brandão P; Freixo M; Soares E; Estevinho C; Carvalho ASP; Melo A
    Rev Bras Ginecol Obstet; 2018 Jun; 40(6):372-376. PubMed ID: 29925108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
    van den Akker ES; Klumper FJ; Brand A; Kanhai HH; Oepkes D
    Vox Sang; 2008 Jul; 95(1):66-9. PubMed ID: 18435678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome in mothers who develop Kell antibodies.
    Boulton FE
    Scott Med J; 1989 Jun; 34(3):454. PubMed ID: 2501868
    [No Abstract]   [Full Text] [Related]  

  • 27. Chorionic biopsy in management of severe Kell alloimmunization.
    Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
    Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cells.
    Wagner T; Berer A; Lanzer G; Geissler K
    Br J Haematol; 2000 Aug; 110(2):409-11. PubMed ID: 10971399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kell sensitization in pregnancy.
    Bowman JM
    Am J Obstet Gynecol; 1986 Oct; 155(4):912-4. PubMed ID: 3766648
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-Kell in pregnancy.
    Leggat HM; Gibson JM; Barron SL; Reid MM
    Br J Obstet Gynaecol; 1991 Feb; 98(2):162-5. PubMed ID: 2004052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-K (kell) antibodies in pregnancy.
    Gunston KD; Moller GH; Botha I
    S Afr Med J; 1991 Feb; 79(3):168-9. PubMed ID: 1994491
    [No Abstract]   [Full Text] [Related]  

  • 32. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 34. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
    Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
    Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A; Lapinski RH; Berkowitz RL
    Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kell expression on myeloid progenitor cells.
    Wagner T; Lanzer G; Geissler K
    Leuk Lymphoma; 2002 Mar; 43(3):479-85. PubMed ID: 12002749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Prediction of the fetal Kell blood group reduces aggressive interventions.
    Araújo F; Monteiro F; Pereira C; Duran J; Nascimento H; Lima L; Cunha A; Storry J; Guimarães J
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):464. PubMed ID: 16171491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.